Autonomous robotic pharmacy startup Queue emerged from stealth with a working system designed to transform how prescriptions are dispensed, verified and delivered. The startup recently closed an oversubscribed $12.6 million seed round led by AlleyCorp, following a $6 million pre-seed round led by Riot Ventures less than a year ago, bringing its total funding to date to $18.6 million.
Additional investors participated in the round include House Capital, Ubiquity Ventures, Grep Ventures and Banter Capital.
Queue was co-founded by Nick Desai, CEO, a six-time venture-backed entrepreneur who previously founded and led Heal, a home healthcare company that raised more than $200 million, and Josh Liu, CTO, whose experience spans Tesla and Zipline.
Queue is building a fully autonomous robotic pharmacy designed to make prescription fulfillment faster, more accessible and cost-effective while supporting rigorous safety and verification protocols. Operating autonomously, Queue’s system takes sealed wholesale pill bottles in one end and produces filled, verified prescription vials out the other. The platform currently supports 250 of the most prescribed medications in the United States.
Queue says it has already secured a major national pharmacy chain as a customer and deployed a working prototype to provide the company with early commercial validation in a market facing urgent labor, cost, and access challenges.
With fresh funds, Queue plans to accelerate its product development efforts, expand deployments with enterprise pharmacy customers and grow the company’s engineering team.
As pharmacy deserts expand, labor shortages persist, and traditional pharmacy economics continue to erode, Queue is positioning autonomous prescription fulfillment as a new infrastructure layer for American healthcare, enabling pharmacy services to move closer to patients while delivering dramatically better economics.